The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Myriad Genetics Inc. (MYGN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.39, or 2.25%, to $17.71. The Myriad Genetics Inc. has recorded 117,736 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities.
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $17.32 and fluctuated between $17.41 as its day high and $16.68 as its day low. The current market capitalization of Myriad Genetics Inc. is $1.37B. A total of 0.58 million shares were traded on the day, compared to an average of 740.79K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, MYGN has seen 1 BUY and 2 SELL insider trades, representing the acquisition of 16,875 and the disposition of 3,318 shares. Over the last 12 months, there were 31 BUYs and 53 SELLs from insiders. Insiders purchased 965,200 shares during that period but sold 251,053.
In the most recent transaction, Riggsbee Richard Bryan sold 20,000 shares of MYGN for 15.15 per share on Dec 27. After the transaction, the Chief Financial Officer now owns 374,107 company shares. In a previous transaction on Jun 06, SPIEGELMAN DANIEL K sold 6,424 shares at 19.25 per share. MYGN shares that Director owns now total 33,980.
Among the insiders who sold shares, Hart Jayne B. disposed of 10,500 shares on Feb 28 at a per-share price of $25.00. This resulted in the Chief People Officer holding 165,878 shares of MYGN after the transaction.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MYGN has a high of $28.18 and a low of $13.92.
As of this writing, MYGN has an earnings estimate of -$0.06 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.03 in the last quarter, which was 57.10% higher than expectations of -$0.07.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MYGN is Buy with a score of 2.57.